| Product Name | MF | CAS | Details |
|---|
| Cytokeratin 16 Blocking Peptide | Details |
| 4-(1H-Pyrazol-4-yl)phenol | C9H8N2O | 191980-64-0 | Details |
| 2-Acetyl-5-bromothiophene | C6H5BrOS | 5370-25-2 | Details |
| SNUPN antibody | Details |
| 1,3-Oxazolidine | C3H7NO | 504-76-7 | Details |
| 4-Bromo-3-cyanoanisole | C8H6BrNO | 138642-47-4 | Details |
| 4-Chloro-2-iodo-1-nitrobenzene | C6H3ClINO2 | 160938-18-1 | Details |
| Ginsenoside Rd | C48H82O18 | 52705-93-8 | Details |
| 1-(4-((6,7-dimethoxy(3,4-dihydroisoquinolyl))methyl)phenyl)-3-(2-fluorophenyl)urea | C25H24FN3O3 | 1022414-37-4 | Details |
| ACP6 antibody | Details |
| 4-[3-[2-Chloro-6-(trifluoromethyl)benzoyl]imidazo[1,5-a]pyridin-1-yl]-2-hydroxybenzoic acid | C22H12ClF3N2O4 | 1677667-24-1 | Details |
| Hepatitis C Virus Nucleocpasid Genotype 2a protein | Details |
| H-ECG-OH | Details |
| N-Boc-cis-4-fluoro-L-proline methyl ester | C11H18FNO4 | 203866-16-4 | Details |
| (+)-MK 801 maleate | C20H19NO4 | 77086-22-7 | Details |
| PCSK2 antibody | Details |
| 4-(Pyrrolidine-1-sulfonyl)piperidine hydrochloride | C9H19ClN2O2S | 1803586-20-0 | Details |
| {7,7-Dimethylbicyclo[2.2.1]heptan-1-yl}methanol | C10H18O | 35122-23-7 | Details |
| 3-Oxo-12α-hydroxy-5β-cholanoic acid | C24H38O4 | 4185-01-7 | Details |
| 2-Chloro-N-(1-phenylethyl)propanamide | C11H14ClNO | 40023-41-4 | Details |
| 2',3',5'-Tri-O-benzoyl-2'-C-methyluridine | C31H26N2O9 | 23643-36-9 | Details |
| (Z)-23-Coumaroylhederagenin | C39H54O6 | 654678-61-2 | Details |
| 4-Methoxy-1H-pyrazole hydrochloride | C4H7ClN2O | 1955531-08-4 | Details |
| Sulfamethazine-d4 | C12H10D4N4O2S | 1020719-82-7 | Details |
| Ethanolamine hydrochloride | C2H8ClNO | 2002-24-6 | Details |
| 1-(1H-Indol-3-yl)-2-methylpropan-2-amine | C12H16N2 | 304-53-0 | Details |
| 2-(4-Bromo-2-chlorophenoxy)propanenitrile | C9H7BrClNO | 951920-69-7 | Details |
| Fatty Acid Synthase antibody | Details |
| Methyl (3S)-3-amino-4-cyclohexylbutanoate hydrochloride | 2173637-95-9 | Details |
| Methyl 1-cyclopentyl-1H-pyrazole-3-carboxylate | C10H14N2O2 | 1006319-34-1 | Details |
| 1-(4-((6,7-dimethoxy(3,4-dihydroisoquinolyl))methyl)phenyl)-3-(4-bromo-2-methylphenyl)urea | C26H26BrN3O3 | 1022700-22-6 | Details |
| 3,5-Dimethoxycyclohexan-1-ol | C8H16O3 | 191865-61-9 | Details |
| Pantoprazole N-oxide | C16H15F2N3O5S | 953787-60-5 | Details |
| E4CPG | C11H13NO4 | 170846-89-6 | Details |
| CDH3 Blocking Peptide | Details |
| H-LLQVAVEDR^-OH | Details |
| 3-Methyl-2-phenylbutyric acid | C11H14O2 | 3508-94-9 | Details |
| 4-Bromo-3,5-dimethylpyridine 1-oxide | C7H8BrNO | 70564-92-0 | Details |
| 5-((3-bromo-4-methoxyphenyl)methylene)-3-ethyl-2-thioxo-1,3-thiazolidin-4-one | C13H12BrNO2S2 | 525570-90-5 | Details |
| Mouse IgG2a Isotyping ELISA kit | Details |
| 1,7,7-Trimethylspiro[bicyclo[2.2.1]heptane-2,4'-imidazolidine]-2',5'-dione | C12H18N2O2 | 6929-30-2 | Details |
| Pdgfrb active human | 101463-26-7 | Details |
| Methyl 2-(1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetate | C13H14O3 | 7430-89-9 | Details |
| H-MVAVPGTVAPRC-OH | Details |
| tert-Butyl({[4-(prop-2-en-1-yloxy)phenyl]methyl})amine hydrochloride | C14H22ClNO | 1158194-77-4 | Details |
| 2-Methyl-4-[(2S)-pyrrolidin-2-yl]-1,3-thiazole | C8H12N2S | 1272743-51-7 | Details |
| 5-Methyl-2-(pyrrolidin-3-yloxy)pyridine dihydrochloride | C10H15ClN2O | 2060024-44-2 | Details |
| SAT2 protein (His tag) | Details |
| 5-?Chloro-?1,?3-?dihydro-?2,?1-?benzisothiazole 2,?2-?dioxide | C7H6ClNO2S | 111310-59-9 | Details |
| 5-Ethynyl-2,3-dihydro-1-benzofuran | C10H8O | 132464-87-0 | Details |
| 2-(2-Aminophenoxy)pyridine-3-carbonitrile | C12H9N3O | 926261-53-2 | Details |
| 2'-O-tert-Butyldimethylsilyl-5'-O-DMT-3-methyluridine 3'-CE phosphoramidite | C46H63N4O9PSi | 179762-50-6 | Details |
| AZ 23 | C17H19ClFN7O | 915720-21-7 | Details |
| (3-Ethoxy-6-methylpyridin-2-yl)methanol | C9H13NO2 | 1228188-12-2 | Details |
| Chlorantholide B | C15H18O3 | 1372558-34-3 | Details |
| 4-Acetyl-3,4-dihydro-2H-pyrido[3,2-b]oxazine | C9H10N2O2 | 89970-14-9 | Details |
| Methyl 6-methyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylate | C10H10N2O2 | 1638764-87-0 | Details |
| TCEB3 antibody | Details |
| 3-Bromo-2-fluoro-5-nitrobenzene-1-sulfonyl chloride | C6H2BrClFNO4S | 1485934-45-9 | Details |
| 3-Bromo-4-(bromomethyl)thiophene | C5H4Br2S | 40032-80-2 | Details |
| 2-[2-(Sulfamoylmethyl)phenyl]acetic acid | C9H11NO4S | 1558450-20-6 | Details |
| 2-[Benzyl(methyl)amino]-5-chlorobenzaldehyde | C15H14ClNO | 1777430-74-6 | Details |
| 4-N-Octyloxybenzamide | C15H23NO2 | 203243-94-1 | Details |
| Sodium decatungstate | NaO32W10(-3) | 126752-51-0 | Details |
| 2-[(Diphenylmethyl)amino]acetic acid hydrochloride | C15H16ClNO2 | 1235439-29-8 | Details |
| Methyl 6-azido-6-deoxy-2,3-di-O-benzyl-a-D-glucopyranoside | C21H25N3O5 | 54522-58-6 | Details |
| H-INHVGGTGGAIMAPVAVTRQLVGS-OH | Details |
| HSP27 antibody (Ser15) | Details |
| 3-[1-(Propan-2-yl)-1H-1,2,3,4-tetrazol-5-yl]aniline | C10H13N5 | 857935-82-1 | Details |
| RCAN2 antibody | Details |
| Spinetoram | 935545-74-7 | Details |
| 4-Bromo-2,5-dimethoxybenzene-1-sulfonamide | C8H10BrNO4S | 1206129-08-9 | Details |
| 2-[2-(Dimethylamino)ethoxy]acetic acid | C6H13NO3 | 98278-28-5 | Details |
| RUG ?, Resorufin-beta-D-glucuronic acid methyl ester, Biosynth Patent: EP 2718458 and US 9127303 | 1415487-42-1 | Details |
| 3-[(3-Methyl-2,5-dioxoimidazolidin-1-yl)methyl]benzonitrile | C12H11N3O2 | 1042646-00-3 | Details |
| Human Prorenin (open form) ELISA (1ea) | Details |
| PDIA3 protein (His tag) | Details |
| 4-Chloro-6-(4-methoxyphenyl)pyrimidine | C11H9ClN2O | 173064-29-4 | Details |
| ESE1 antibody | Details |
| [(4-Fluorophenyl)methyl](pentyl)amine | C12H18FN | 847744-11-0 | Details |
| Intrinsic Factor Antibody Positive Human Plasma | Details |
| 4-Chloro-N,N-dimethylcathinone hydrochloride | C11H15Cl2NO | 2493977-47-0 | Details |
| 1,3-Dichloro-5H,6H,7H-cyclopenta[C]pyridine-4-carbonitrile | C9H6Cl2N2 | 15524-46-6 | Details |
| 2-Amino-2-(2-methoxyquinolin-3-yl)ethan-1-ol | 1823708-33-3 | Details |
| Isopropyl-(1-methyl-1 H -imidazol-2-ylmethyl)-amine | C8H15N3 | 474056-47-8 | Details |
| 2-{[3-(4-Chlorophenyl)-4-oxo-3,4-dihydroquinazolin-2-yl]sulfanyl}acetohydrazide | C16H13ClN4O2S | 133764-45-1 | Details |
| 6-Oxa-1-azaspiro[3.5]nonane hydrochloride | C7H14ClNO | 1956324-37-0 | Details |
| 3-Bromo-1-[4-(difluoromethoxy)phenyl]piperidin-2-one | C12H12BrF2NO2 | 1354949-37-3 | Details |
| 1-Bromo-2-(chloromethyl)-3-fluoro-4-methoxybenzene | C8H7BrClFO | 1516298-29-5 | Details |
| 4-(4-Methylphenyl)but-3-enoic acid | C11H12O2 | 127404-74-4 | Details |
| (R)-(4-Fluoro-2-propylphenyl)(1H-imidazol-2-yl)methanol | C13H15FN2O | 2100285-41-2 | Details |
| H-EESDDDMGFGLFD-OH | Details |
| 5-Cyano-2-methoxybenzenesulfonyl chloride | C8H6ClNO3S | 409359-25-7 | Details |
| 5-(1-Acetylpiperidin-2-yl)-1-methyl-1H-pyrrole-2-carboxylic acid | C13H18N2O3 | 1788685-73-3 | Details |
| IL-1alpha Antibody, Biotin | Details |
| [D-Trp34]-Neuropeptide Y | C196H289N55O56 | 153549-84-9 | Details |
| H-LGKGGAKRHRKVLRDNIQGIT-NTPEGBiot | Details |
| LHCGR antibody | Details |
| 8-Fluoro-7-methoxy-2,4-dihydro-1H-3,1-benzoxazine-2,4-dione | C9H6FNO4 | 2137981-19-0 | Details |
| 2-Butyl-2,3-dihydro-1H-isoindol-5-amine | C12H18N2 | 1099643-57-8 | Details |
| Product Total： Product Page： | ||||
| 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 | ||||